Human B Lymphocyte In Vitro Response to the Group B Streptococcal Type III Capsular Carbohydrate

Anti-group B streptococcal type III polysaccharide-specific human B cells from the peripheral circulation can be activated and delected in an in vitro culture system. It is possible to detect both IgM- and IgG-producing cells from both seropositive and seronegative donors. The specificity of the response was demonstrated by inhibition with excess liquid phase antigen and the use of related but antigenically distinct control antigens. The response was absent without the addition of T cells, optimal at 10% and 25% T cells respectively for IgM- and IgG-secreting cells, and undetectable using 50% T cells. The optimal antigen concentration for in vitro B-cell activation is 2.5 × 10⁻⁴ μ /ml. Cells from 5 of 6 seropositive donors and 3 of 7 seronegative donors produced specific IgM antibody after culture with antigen. We conclude that the control of the human antibody response to the group B streptococcal type III polysaccharide is influenced by T cells. The response seen in the culture system may be of value in assessing future vaccine candidates designed to prevent neonatal infections.